Celldex Therapeutics recruits highly motivated and talented people in order to build a strong and diverse workforce, which is working to develop targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline of drug candidates is comprised of therapeutic antibodies, antibody-drug conjugates, immune system modulators and other protein-based therapeutics that we believe have a higher probability of success because they are targeted to specific patient populations with high unmet medical need whose diseases express specific markers. This has created a leading pipeline in immunotherapy and targeted cancer therapies with six company-led clinical trials across six product candidates, including a registration study in triple negative breast cancer and five Phase 1 and Phase 2 clinical trials in a range of difficult-to-treat indications, and a robust preclinical engine.
Please explore our open positions, and find your fit on our team. Apply through this website, or share with colleagues whom you feel would make a great match. We encourage you to check back frequently as we regularly post new opportunities.